{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:01:38Z","timestamp":1766048498054},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,8,26]],"date-time":"2014-08-26T00:00:00Z","timestamp":1409011200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s10495-014-1029-5","type":"journal-article","created":{"date-parts":[[2014,8,25]],"date-time":"2014-08-25T13:27:25Z","timestamp":1408973245000},"page":"1616-1626","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Gamma secretase inhibitors enhance vincristine-induced apoptosis in T-ALL in a NOTCH-independent manner"],"prefix":"10.1007","volume":"19","author":[{"given":"Sun-Ok","family":"Yoon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana C.","family":"Zapata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akannsha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wol Soon","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nakia","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Sung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,26]]},"reference":[{"key":"1029_CR1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","volume":"354","author":"CH Pui","year":"2006","unstructured":"Pui CH, Evans WE (2006) Treatment of acute lymphoblastic leukemia. N Engl J Med 354:166\u2013178","journal-title":"N Engl J Med"},{"key":"1029_CR2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2141.2011.08957.x","volume":"156","author":"MD Kraszewska","year":"2012","unstructured":"Kraszewska MD, Dawidowska M, Szczepanski T, Witt M (2012) T-cell acute lymphoblastic leukaemia: recent molecular biology findings. Br J Haematol 156:303\u2013315","journal-title":"Br J Haematol"},{"key":"1029_CR3","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1172\/JCI61269","volume":"122","author":"P Vlierberghe Van","year":"2012","unstructured":"Van Vlierberghe P, Ferrando A (2012) The molecular basis of T cell acute lymphoblastic leukemia. J Clin Invest 122:3398\u20133406","journal-title":"J Clin Invest"},{"key":"1029_CR4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrc1880","volume":"6","author":"C Grabher","year":"2006","unstructured":"Grabher C, von Boehmer H, Look AT (2006) Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer 6:347\u2013359","journal-title":"Nat Rev Cancer"},{"key":"1029_CR5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.it.2011.06.005","volume":"32","author":"U Koch","year":"2011","unstructured":"Koch U, Radtke F (2011) Notch in T-ALL: new players in a complex disease. Trends Immunol 32:434\u2013442","journal-title":"Trends Immunol"},{"key":"1029_CR6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","volume":"306","author":"AP Weng","year":"2004","unstructured":"Weng AP, Ferrando AA, Lee W, Morris JPt, Silverman LB et al (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306:269\u2013271","journal-title":"Science"},{"key":"1029_CR7","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1084\/jem.183.5.2283","volume":"183","author":"WS Pear","year":"1996","unstructured":"Pear WS, Aster JC, Scott ML, Hasserjian RP, Soffer B et al (1996) Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med 183:2283\u20132291","journal-title":"J Exp Med"},{"key":"1029_CR8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/sj.leu.2404546","volume":"21","author":"J Chen","year":"2007","unstructured":"Chen J, Jette C, Kanki JP, Aster JC, Look AT et al (2007) NOTCH1-induced T-cell leukemia in transgenic zebrafish. Leukemia 21:462\u2013471","journal-title":"Leukemia"},{"key":"1029_CR9","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/MCB.23.2.655-664.2003","volume":"23","author":"AP Weng","year":"2003","unstructured":"Weng AP, Nam Y, Wolfe MS, Pear WS, Griffin JD et al (2003) Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling. Mol Cell Biol 23:655\u2013664","journal-title":"Mol Cell Biol"},{"key":"1029_CR10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1182\/blood-2006-08-039883","volume":"110","author":"SM Chan","year":"2007","unstructured":"Chan SM, Weng AP, Tibshirani R, Aster JC, Utz PJ (2007) Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia. Blood 110:278\u2013286","journal-title":"Blood"},{"key":"1029_CR11","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1084\/jem.20070876","volume":"204","author":"J O\u2019Neil","year":"2007","unstructured":"O\u2019Neil J, Grim J, Strack P, Rao S, Tibbitts D et al (2007) FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med 204:1813\u20131824","journal-title":"J Exp Med"},{"key":"1029_CR12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3324\/haematol.11894","volume":"93","author":"K Keersmaecker De","year":"2008","unstructured":"De Keersmaecker K, Lahortiga I, Mentens N, Folens C, Van Neste L et al (2008) In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia. Haematologica 93:533\u2013542","journal-title":"Haematologica"},{"key":"1029_CR13","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1158\/1535-7163.MCT-11-0938","volume":"11","author":"JB Samon","year":"2012","unstructured":"Samon JB, Castillo-Martin M, Hadler M, Ambesi-Impiobato A, Paietta E et al (2012) Preclinical analysis of the gamma-secretase inhibitor PF-03084014 in combination with glucocorticoids in T-cell acute lymphoblastic leukemia. Mol Cancer Ther 11:1565\u20131575","journal-title":"Mol Cancer Ther"},{"key":"1029_CR14","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1111\/j.1349-7006.2009.01328.x","volume":"100","author":"S Masuda","year":"2009","unstructured":"Masuda S, Kumano K, Suzuki T, Tomita T, Iwatsubo T et al (2009) Dual antitumor mechanisms of Notch signaling inhibitor in a T-cell acute lymphoblastic leukemia xenograft model. Cancer Sci 100:2444\u20132450","journal-title":"Cancer Sci"},{"key":"1029_CR15","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1476-5381.2009.00389.x","volume":"158","author":"J Tammam","year":"2009","unstructured":"Tammam J, Ware C, Efferson C, O\u2019Neil J, Rao S et al (2009) Down-regulation of the Notch pathway mediated by a gamma-secretase inhibitor induces anti-tumour effects in mouse models of T-cell leukaemia. Br J Pharmacol 158:1183\u20131195","journal-title":"Br J Pharmacol"},{"key":"1029_CR16","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1158\/1535-7163.MCT-10-0034","volume":"9","author":"P Wei","year":"2010","unstructured":"Wei P, Walls M, Qiu M, Ding R, Denlinger RH et al (2010) Evaluation of selective gamma-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial design. Mol Cancer Ther 9:1618\u20131628","journal-title":"Mol Cancer Ther"},{"key":"1029_CR17","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1158\/0008-5472.CAN-08-4295","volume":"69","author":"S Rao","year":"2009","unstructured":"Rao S, O\u2019Neil J, Liberator C, Hardwick J, Dai X et al (2009) Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells. Cancer Res 69:3060\u20133068","journal-title":"Cancer Res"},{"key":"1029_CR18","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1182\/blood-2008-02-136762","volume":"113","author":"K Cullion","year":"2009","unstructured":"Cullion K, Draheim K, Hermance N, Tammam J, Sharma V et al (2009) Targeting the Notch1 and mTOR pathways in a mouse T-ALL model. Blood 113:6172\u20136181","journal-title":"Blood"},{"key":"1029_CR19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/ng.2913","volume":"46","author":"B Knoechel","year":"2014","unstructured":"Knoechel B, Roderick JE, Williamson KE, Zhu J, Lohr JG et al (2014) An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia. Nat Genet 46:364\u2013370","journal-title":"Nat Genet"},{"key":"1029_CR20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nm.1900","volume":"15","author":"PJ Real","year":"2009","unstructured":"Real PJ, Tosello V, Palomero T, Castillo M, Hernando E et al (2009) Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nat Med 15:50\u201358","journal-title":"Nat Med"},{"key":"1029_CR21","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1636","volume":"13","author":"T Palomero","year":"2007","unstructured":"Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K et al (2007) Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 13:1203\u20131210","journal-title":"Nat Med"},{"key":"1029_CR22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/34910","volume":"391","author":"B Strooper De","year":"1998","unstructured":"De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G et al (1998) Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391:387\u2013390","journal-title":"Nature"},{"key":"1029_CR23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/19077","volume":"398","author":"MS Wolfe","year":"1999","unstructured":"Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT et al (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398:513\u2013517","journal-title":"Nature"},{"key":"1029_CR24","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1021\/bi901388t","volume":"49","author":"L Placanica","year":"2010","unstructured":"Placanica L, Chien JW, Li YM (2010) Characterization of an atypical gamma-secretase complex from hematopoietic origin. Biochemistry 49:2796\u20132804","journal-title":"Biochemistry"},{"key":"1029_CR25","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1182\/blood-2004-02-0514","volume":"104","author":"I Maillard","year":"2004","unstructured":"Maillard I, Weng AP, Carpenter AC, Rodriguez CG, Sai H et al (2004) Mastermind critically regulates Notch-mediated lymphoid cell fate decisions. Blood 104:1696\u20131702","journal-title":"Blood"},{"key":"1029_CR26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.chembiol.2006.12.010","volume":"14","author":"HD Lewis","year":"2007","unstructured":"Lewis HD, Leveridge M, Strack PR, Haldon CD, O\u2019Neil J et al (2007) Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling. Chem Biol 14:209\u2013219","journal-title":"Chem Biol"},{"key":"1029_CR27","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1182\/blood-2002-11-3612","volume":"102","author":"A Holleman","year":"2003","unstructured":"Holleman A, den Boer ML, Kazemier KM, Janka-Schaub GE, Pieters R (2003) Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia. Blood 102:4541\u20134546","journal-title":"Blood"},{"key":"1029_CR28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.gastro.2007.10.008","volume":"134","author":"T Akiyoshi","year":"2008","unstructured":"Akiyoshi T, Nakamura M, Yanai K, Nagai S, Wada J et al (2008) Gamma-secretase inhibitors enhance taxane-induced mitotic arrest and apoptosis in colon cancer cells. Gastroenterology 134:131\u2013144","journal-title":"Gastroenterology"},{"key":"1029_CR29","first-page":"4999","volume":"30","author":"T Tasaka","year":"2010","unstructured":"Tasaka T, Akiyoshi T, Yamaguchi K, Tanaka M, Onishi H et al (2010) Gamma-secretase complexes regulate the responses of human pancreatic ductal adenocarcinoma cells to taxanes. Anticancer Res 30:4999\u20135010","journal-title":"Anticancer Res"},{"key":"1029_CR30","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1091\/mbc.02-02-0030.","volume":"13","author":"ML Whitfield","year":"2002","unstructured":"Whitfield ML, Sherlock G, Saldanha AJ, Murray JI, Ball CA et al (2002) Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell 13:1977\u20132000","journal-title":"Mol Biol Cell"},{"key":"1029_CR31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.neurobiolaging.2006.10.027","volume":"29","author":"DI Boeras","year":"2008","unstructured":"Boeras DI, Granic A, Padmanabhan J, Crespo NC, Rojiani AM et al (2008) Alzheimer\u2019s presenilin 1 causes chromosome missegregation and aneuploidy. Neurobiol Aging 29:319\u2013328","journal-title":"Neurobiol Aging"},{"key":"1029_CR32","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1182\/blood.V99.11.4100","volume":"99","author":"RB Lock","year":"2002","unstructured":"Lock RB, Liem N, Farnsworth ML, Milross CG, Xue C et al (2002) The nonobese diabetic\/severe combined immunodeficient (NOD\/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse. Blood 99:4100\u20134108","journal-title":"Blood"},{"key":"1029_CR33","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1182\/blood-2003-08-2911","volume":"103","author":"NL Liem","year":"2004","unstructured":"Liem NL, Papa RA, Milross CG, Schmid MA, Tajbakhsh M et al (2004) Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies. Blood 103:3905\u20133914","journal-title":"Blood"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-014-1029-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10495-014-1029-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-014-1029-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T18:41:34Z","timestamp":1559155294000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10495-014-1029-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,26]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["1029"],"URL":"https:\/\/doi.org\/10.1007\/s10495-014-1029-5","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,26]]}}}